| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,151,697 |
|
|
Indirect Shares
|
265,510 |
|
|
| Direct
Value |
$8,534,238 |
|
|
|
Indirect Value
|
$109,674 |
|
|
| Total
Shares |
1,417,207 |
|
|
| Total
Value |
$8,643,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Director |
– • – |
2011-11-28 |
4 |
B |
$5.40 |
$540,000 |
D/D |
100,000 |
407,304 |
2.39 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2014-10-27 |
4 |
S |
$102.85 |
$10,284,630 |
D/D |
(100,000) |
129,358 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-09-13 |
4 |
B |
$0.79 |
$79,180 |
D/D |
100,000 |
530,724 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-10-31 |
4 |
B |
$0.00 |
$0 |
D/D |
100,000 |
630,724 |
2.31 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2013-11-08 |
4 |
S |
$11.73 |
$1,351,503 |
D/D |
(115,200) |
394,959 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-06-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
115,500 |
193,069 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2016-11-23 |
4 |
B |
$0.41 |
$48,600 |
I/I |
120,000 |
120,000 |
2.1 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2015-11-16 |
4 |
S |
$17.63 |
$2,203,163 |
D/D |
(125,000) |
86,032 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2015-12-29 |
4 |
B |
$7.09 |
$886,613 |
D/D |
125,000 |
262,637 |
2.39 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Director |
– • – |
2013-04-26 |
4 |
OE |
$0.40 |
$66,667 |
D/D |
166,667 |
1,447,079 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-12-03 |
4 |
A |
$0.00 |
$0 |
I/I |
200,000 |
200,000 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
210,251 |
1,477,771 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2015-08-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
210,251 |
1,537,771 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-12-05 |
4 |
D |
$33.25 |
$7,140,438 |
D/D |
(214,750) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-12-27 |
4/A |
GD |
$0.00 |
$0 |
D/D |
244,230 |
192,027 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2007-12-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
244,230 |
192,097 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-12-05 |
4 |
D |
$33.25 |
$8,755,157 |
I/I |
(263,313) |
0 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2014-11-18 |
4 |
B |
$0.00 |
$0 |
I/I |
466,200 |
632,720 |
2.17 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2014-11-18 |
4 |
S |
$0.00 |
$0 |
D/D |
(471,192) |
0 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
786,645 |
1,267,520 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
930,000 |
2,363,135 |
2.31 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
930,000 |
930,000 |
2.02 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2014-11-18 |
4 |
S |
$0.00 |
$0 |
I/I |
(1,019,426) |
0 |
0 |
- |
|
373 Records found
|
|
Page 15 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
